Skip to main content
Fig. 8 | The Journal of Headache and Pain

Fig. 8

From: Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders

Fig. 8

Galcanezumab effects on incidence of headache after occurrence of aura in responders vs. non-responders (A), and super-responders vs. super non-responders (B). Complete absence of effect in the super non-responders suggest the galcanezumab ability to reduce incidence of headache after aura is secondary to the reduction in migraine days per month

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us